Literature DB >> 9346722

Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD).

S H Belle1, M K Porayko, J H Hoofnagle, J R Lake, R K Zetterman.   

Abstract

Quality of life is an important factor to consider when assessing the value of liver transplantation. Using a large, prospective database of liver transplantation recipients from three clinical centers in the United States, we examined the quality of life of 346 adults before and 1 year after surgery. Five quality of life domains were evaluated (measures of disease, psychological distress and well-being, personal function, social/role function, and general health perception) with standardized questionnaires completed according to established protocol. The largest numbers of patients were distressed by fatigue and muscle weakness, both before transplantation and 1 year after surgery. Compared to baseline, recipients at follow-up noted fewer disease-related symptoms (P < .001) and lower levels of distress overall (P < .001). However, levels of distress due to excess appetite (P < .001), headaches (P = .02), and poor/blurred vision (P = .05) were more likely to increase than decrease. Although 57% to 64% of the recipients were distressed by each of the psychological conditions examined at follow-up, distress was more likely to decrease than increase (P < .001), and well-being was comparable to the general population. All measures of personal functioning improved significantly (P < .05). Fifty-eight percent of the patients prevented by their disease from going to work or school before transplantation were no longer so limited at follow-up. With the exception of marriage (P = .23), all facets of social/role functioning improved more often than worsened (P < .01). Perception of health improved remarkably, with 13.4 times as many recipients reporting improved health as reporting worse health (P < .001). We conclude that liver transplantation markedly improves the quality of life of patients with end-stage liver disease.

Entities:  

Mesh:

Year:  1997        PMID: 9346722     DOI: 10.1002/lt.500030201

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  17 in total

1.  Barriers preventing liver transplantation in Canadians with HIV-infection--perceptions of HIV specialists.

Authors:  Curtis L Cooper; Joanne DeForest; John Gill; Richard Lalonde
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

Review 2.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease.

Authors:  Z M Younossi; G Guyatt; M Kiwi; N Boparai; D King
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 4.  Medical problems occurring after orthotopic liver transplantation.

Authors:  K L Carson; C M Hunt
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

5.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

Review 6.  A review of quality of life instruments used in liver transplantation.

Authors:  Colleen L Jay; Zeeshan Butt; Daniela P Ladner; Anton I Skaro; Michael M Abecassis
Journal:  J Hepatol       Date:  2009-07-28       Impact factor: 25.083

Review 7.  Metabolic complications in liver transplant recipients.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; Edith Omonte Guzmán; Víctor Amo Trillo; Juan Miguel Rodrigo López
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

8.  Health status versus utilities of patients with end-stage liver disease.

Authors:  Cindy L Bryce; Derek C Angus; JoAnn Switala; Mark S Roberts; Joel Tsevat
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

Review 9.  Fatigue in liver disease: pathophysiology and clinical management.

Authors:  Mark G Swain
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

10.  Physical fitness, fatigue, and quality of life after liver transplantation.

Authors:  Berbke T J van Ginneken; Rita J G van den Berg-Emons; Geert Kazemier; Herold J Metselaar; Hugo W Tilanus; Henk J Stam
Journal:  Eur J Appl Physiol       Date:  2007-03-16       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.